{"id":"https://openalex.org/W4283366697","doi":"https://doi.org/10.1097/01.hs9.0000850164.28901.b2","title":"PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN","display_name":"PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4283366697","doi":"https://doi.org/10.1097/01.hs9.0000850164.28901.b2"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000850164.28901.b2","doi":"https://doi.org/10.1097/01.hs9.0000850164.28901.b2","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000850164.28901.b2","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000850164.28901.b2","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088307376","display_name":"Naveen Pemmaraju","orcid":"https://orcid.org/0000-0002-1670-6513","observed_orcids":["https://orcid.org/0000-0002-1670-6513"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"N. Pemmaraju","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073761054","display_name":"Giovanni Martinelli","orcid":"https://orcid.org/0000-0002-1025-4210","observed_orcids":["https://orcid.org/0000-0002-1025-4210"]},"institutions":[{"id":"https://openalex.org/I4210117483","display_name":"Istituto di Ematologia di Bologna","ror":"https://ror.org/01mze9517","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210117483"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. Martinelli","raw_affiliation_strings":["Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. e A. Ser\u00e0gnoli\u201d, Bologna"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology \u201cL. e A. Ser\u00e0gnoli\u201d, Bologna","institution_ids":["https://openalex.org/I4210117483"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018098518","display_name":"Elisabetta Todisco","orcid":"https://orcid.org/0000-0002-9622-6746","observed_orcids":["https://orcid.org/0000-0002-9622-6746"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"E. Todisco","raw_affiliation_strings":["Division of Onco-Hematology, European Institute of Oncology IRCCS, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Onco-Hematology, European Institute of Oncology IRCCS, Milano, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058765211","display_name":"Corrado Tarella","orcid":"https://orcid.org/0000-0003-1473-6046","observed_orcids":["https://orcid.org/0000-0003-1473-6046"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"C. Tarella","raw_affiliation_strings":["Division of Onco-Hematology, European Institute of Oncology IRCCS, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Onco-Hematology, European Institute of Oncology IRCCS, Milano, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003682435","display_name":"Pau Montesinos","orcid":"https://orcid.org/0000-0002-3275-5593","observed_orcids":["https://orcid.org/0000-0002-3275-5593"]},"institutions":[{"id":"https://openalex.org/I3019010403","display_name":"Hospital Universitari i Polit\u00e8cnic La Fe","ror":"https://ror.org/01ar2v535","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I3019010403","https://openalex.org/I4210166036"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"P. Montesinos","raw_affiliation_strings":["Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitari i Polit\u00e8cnic La Fe, Valencia, Spain","institution_ids":["https://openalex.org/I3019010403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069401963","display_name":"Andrew A. Lane","orcid":"https://orcid.org/0000-0001-7380-0226","observed_orcids":["https://orcid.org/0000-0001-7380-0226"]},"institutions":[{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. A. Lane","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber/Boston Children\u2019s Cancer and Blood Disorders Ctr, Boston","Department of Medical Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Ctr, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber/Boston Children\u2019s Cancer and Blood Disorders Ctr, Boston","institution_ids":["https://openalex.org/I4210166317"]},{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Ctr, Boston","institution_ids":["https://openalex.org/I4210166317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050556099","display_name":"Harry Paul Erba","orcid":"https://orcid.org/0000-0003-1093-2189","observed_orcids":["https://orcid.org/0000-0003-1093-2189"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. P. Erba","raw_affiliation_strings":["Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057933586","display_name":"Kendra Lynn Sweet","orcid":"https://orcid.org/0000-0001-6248-3317","observed_orcids":["https://orcid.org/0000-0001-6248-3317"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. L. Sweet","raw_affiliation_strings":["Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013626352","display_name":"Roland B. Walter","orcid":"https://orcid.org/0000-0002-9268-3341","observed_orcids":["https://orcid.org/0000-0002-9268-3341"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. B. Walter","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, United States of America","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019961853","display_name":"\u00c9ric Deconinck","orcid":"https://orcid.org/0000-0002-6006-8088","observed_orcids":["https://orcid.org/0000-0002-6006-8088"]},"institutions":[{"id":"https://openalex.org/I4210087978","display_name":"Centre Hospitalier Universitaire de Besan\u00e7on","ror":"https://ror.org/0084te143","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210087978"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Deconinck","raw_affiliation_strings":["Clinical Hematology, Besan\u00e7on University Hospital, Besan\u00e7on, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Hematology, Besan\u00e7on University Hospital, Besan\u00e7on, France","institution_ids":["https://openalex.org/I4210087978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069211964","display_name":"E. S. Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. S. Wang","raw_affiliation_strings":["Roswell Park Comprehensive Cancer Center, Buffalo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Comprehensive Cancer Center, Buffalo","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038541414","display_name":"Ahmed M. Aribi","orcid":"https://orcid.org/0000-0003-2497-3176","observed_orcids":["https://orcid.org/0000-0003-2497-3176"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Aribi","raw_affiliation_strings":["Gehr Family Center for Leukemia Research, City of Hope, Duarte"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gehr Family Center for Leukemia Research, City of Hope, Duarte","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013730166","display_name":"Matthew L. Ulrickson","orcid":"https://orcid.org/0000-0002-1458-7813","observed_orcids":["https://orcid.org/0000-0002-1458-7813"]},"institutions":[{"id":"https://openalex.org/I2802412784","display_name":"Banner Health","ror":"https://ror.org/039wwwz66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802412784"]},{"id":"https://openalex.org/I4387154023","display_name":"Banner MD Anderson Cancer Center","ror":"https://ror.org/049c9q337","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I2802412784","https://openalex.org/I4387154023"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. L. Ulrikson","raw_affiliation_strings":["Banner Health MD Anderson Cancer Center, Gilbert"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Banner Health MD Anderson Cancer Center, Gilbert","institution_ids":["https://openalex.org/I2802412784","https://openalex.org/I4387154023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036543091","display_name":"Moshe Yair Levy","orcid":"https://orcid.org/0000-0002-2570-6128","observed_orcids":["https://orcid.org/0000-0002-2570-6128"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Y. Levy","raw_affiliation_strings":["Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043485385","display_name":"Delphine Lebon","orcid":"https://orcid.org/0000-0002-4073-1559","observed_orcids":["https://orcid.org/0000-0002-4073-1559"]},"institutions":[{"id":"https://openalex.org/I4210096553","display_name":"Centre Hospitalier Universitaire Amiens-Picardie","ror":"https://ror.org/010567a58","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210096553"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D. Lebon","raw_affiliation_strings":["Department of Clinical Hematology and Cellular Therapy, Amiens University Medical Center, Amiens, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Hematology and Cellular Therapy, Amiens University Medical Center, Amiens, France","institution_ids":["https://openalex.org/I4210096553"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025719686","display_name":"Giovanni Marconi","orcid":"https://orcid.org/0000-0001-6309-0515","observed_orcids":["https://orcid.org/0000-0001-6309-0515"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Marconi","raw_affiliation_strings":["Istituto Seragnoli, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Seragnoli, Bologna, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082924494","display_name":"Daniel J. DeAngelo","orcid":"https://orcid.org/0000-0001-7865-2306","observed_orcids":["https://orcid.org/0000-0001-7865-2306"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. J. DeAngelo","raw_affiliation_strings":["Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074431173","display_name":"Dustin Rizzieri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Rizzieri","raw_affiliation_strings":["Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112374856","display_name":"Marina Konopleva","orcid":"https://orcid.org/0000-0002-9347-2212","observed_orcids":["https://orcid.org/0000-0002-9347-2212"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Konopleva","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089572805","display_name":"Callum Mortimer Sloss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. M. Sloss","raw_affiliation_strings":["ImmunoGen, Inc., Waltham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen, Inc., Waltham, United States of America","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Wang","raw_affiliation_strings":["ImmunoGen, Inc., Waltham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen, Inc., Waltham, United States of America","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073022384","display_name":"K. A. Malcolm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. A. Malcolm","raw_affiliation_strings":["ImmunoGen, Inc., Waltham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen, Inc., Waltham, United States of America","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006250220","display_name":"Patrick A. Zweidler\u2010McKay","orcid":"https://orcid.org/0000-0001-6621-523X","observed_orcids":["https://orcid.org/0000-0001-6621-523X"]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. A. Zweidler-McKay","raw_affiliation_strings":["ImmunoGen, Inc., Waltham, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen, Inc., Waltham, United States of America","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035605515","display_name":"Naval Guastad Daver","orcid":"https://orcid.org/0000-0001-7103-373X","observed_orcids":["https://orcid.org/0000-0001-7103-373X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. G. Daver","raw_affiliation_strings":["Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":19,"corresponding_author_ids":["https://openalex.org/A5088307376"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":0.2818,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.51765417,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"6","issue":null,"first_page":"1708","last_page":"1709"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.15369999408721924,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.15369999408721924,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.10209999978542328,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.08429999649524689,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/blastic-plasmacytoid-dendritic-cell-neoplasm","display_name":"blastic plasmacytoid dendritic cell neoplasm","score":0.949999988079071},{"id":"https://openalex.org/keywords/cd123","display_name":"CD123","score":0.8870000243186951},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9909999966621399},{"id":"https://openalex.org/keywords/frontline-treatment","display_name":"frontline treatment","score":0.41499999165534973},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7310000061988831},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6620000004768372},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.6420000195503235},{"id":"https://openalex.org/keywords/hepatic-veno-occlusive-disease","display_name":"veno-occlusive disease","score":0.7269999980926514},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.4390000104904175},{"id":"https://openalex.org/keywords/relapsed-refractory-disease","display_name":"relapsed/refractory disease","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8486425876617432},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.553003191947937},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5423248410224915},{"id":"https://openalex.org/C83396363","wikidata":"https://www.wikidata.org/wiki/Q21116062","display_name":"Interleukin-3 receptor","level":3,"score":0.5318875908851624},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47069811820983887},{"id":"https://openalex.org/C194409129","wikidata":"https://www.wikidata.org/wiki/Q103824","display_name":"Hematology","level":2,"score":0.46328702569007874},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.4423113763332367},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34268903732299805},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.32737571001052856},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.29679417610168457},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000850164.28901.b2","doi":"https://doi.org/10.1097/01.hs9.0000850164.28901.b2","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000850164.28901.b2","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9431197","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9431197","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:5695b2284b4b49e8929b97c2495bc8f4","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/5695b2284b4b49e8929b97c2495bc8f4","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 6, Pp 1708-1709 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000850164.28901.b2","doi":"https://doi.org/10.1097/01.hs9.0000850164.28901.b2","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000850164.28901.b2","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8600000143051147,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4311628015","https://openalex.org/W3191427281","https://openalex.org/W2087016115","https://openalex.org/W2305775430","https://openalex.org/W2783315223","https://openalex.org/W1990197915","https://openalex.org/W2465571689","https://openalex.org/W3013383813","https://openalex.org/W2427186628","https://openalex.org/W2749516410"],"abstract_inverted_index":{"Background:":[0],"Overexpression":[1],"of":[2,67,121,137,178,191,203,206,230,250],"CD123":[3,35],"occurs":[4],"in":[5,90,99,139,154,169,290,300],"multiple":[6],"hematological":[7],"malignancies,":[8],"including":[9],"blastic":[10],"plasmacytoid":[11],"dendritic":[12],"cell":[13],"neoplasm":[14],"(BPDCN),":[15],"acute":[16,20],"myeloid":[17],"leukemia":[18,22],"(AML),":[19],"lymphoblastic":[21],"(ALL)":[23],"and":[24,82,147,150,164,228,271],"others.":[25],"With":[26],"limited":[27],"expression":[28],"on":[29],"normal":[30,105],"hematopoietic":[31,106],"progenitor":[32],"cells,":[33],"the":[34,68,225,291,301],"antigen":[36],"is":[37,45,141,221],"an":[38],"attractive":[39],"target":[40],"for":[41,182,264,274,304],"new":[42],"therapeutics.":[43],"IMGN632":[44,74,126,138,183,231],"a":[46,52,58,62,86,245,261],"CD123-targeting":[47],"antibody-drug":[48],"conjugate":[49],"(ADC)":[50],"comprising":[51],"novel":[53],"anti-CD123":[54],"antibody":[55],"coupled,":[56],"via":[57],"peptide":[59],"linker,":[60],"to":[61,104,125,175,208,223,234],"unique":[63],"DNA-alkylating":[64],"cytotoxic":[65],"payload":[66],"IGN":[69],"(indolinobenzodiazepine":[70],"pseudodimer)":[71],"class.":[72],"Preclinically,":[73],"has":[75],"demonstrated":[76,128],"potent":[77],"activity":[78,229],"against":[79],"BPDCN,":[80],"AML,":[81],"ALL":[83],"models,":[84,92],"with":[85,201,236,276,282],"wide":[87],"therapeutic":[88],"index":[89],"animal":[91],"as":[93,95],"well":[94],"150-fold":[96],"differential":[97],"cytotoxicity":[98],"AML":[100],"patient-derived":[101,123],"samples":[102],"compared":[103],"progenitors":[107],"(Kovtun.":[108],"Blood":[109,130],"Adv":[110],"(2018)":[111,131],"2(8):848,":[112],"Angelova.":[113],"Haematologica":[114],"(2019)":[115],"104(4):749).":[116],"In":[117],"particular,":[118],"remarkable":[119],"sensitivity":[120],"BPDCN":[122,140,173,194,266,293,306],"xenografts":[124],"was":[127],"(Zhang":[129],"132:3956).":[132],"The":[133,240],"clinical":[134,197],"safety":[135],"profile":[136],"characterized":[142],"by":[143],"low-grade":[144],"peripheral":[145],"edema":[146],"infusion":[148],"reactions,":[149],"reversible":[151],"veno-occlusive":[152],"disease":[153,286],"<":[155],"5%;":[156],"there":[157],"have":[158,187],"been":[159],"no":[160,165],"capillary":[161],"leak":[162],"syndrome":[163],"treatment-related":[166],"deaths.":[167],"Data":[168],"relapsed":[170,277],"or":[171,278],"refractory":[172,279],"led":[174],"FDA":[176],"granting":[177],"Breakthrough":[179],"Therapy":[180],"Designation":[181],"(October":[184],"2020).":[185],"We":[186],"previously":[188],"reported":[189],"three":[190,192],"frontline":[193,237,292],"patients":[195,235,275],"achieved":[196],"complete":[198],"responses":[199],"(CRc)":[200],"duration":[202],"response":[204],"(DOR)":[205],"up":[207],"10.7":[209],"months":[210],"without":[211],"transplant":[212],"(Pemmaraju.":[213],"ASH":[214],"2021":[215],"Abstract":[216],"#1284).":[217],"Aims:":[218],"This":[219],"study":[220],"designed":[222],"determine":[224],"safety,":[226],"tolerability,":[227],"when":[232],"administered":[233],"BPDCN.":[238,280],"Methods:":[239],"dose":[241,249],"escalation":[242],"phase":[243,247],"identified":[244],"recommended":[246],"2":[248],"0.045":[251],"mg/kg":[252],"given":[253],"intravenously":[254],"every":[255],"3":[256],"weeks.":[257],"Expansion":[258],"cohorts":[259,273],"include":[260],"pivotal":[262,302],"cohort":[263,303],"frontline/untreated":[265,305],"(no":[267],"prior":[268],"systemic":[269],"therapy),":[270],"exploratory":[272],"Patients":[281],"central":[283],"nervous":[284],"system":[285],"are":[287],"not":[288],"eligible":[289],"cohort.":[294],"Results:":[295],"N/A":[296],"Summary/Conclusion:":[297],"Enrollment":[298],"continues":[299],"patients.":[307],"CADENZA,":[308],"https://BPDCNtrial.com,":[309],"NCT03386513":[310]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}